Drugs & Aging delivers essential information on the most important aspects of drug therapy to researchers and healthcare professionals involved in the care of older patients.
Through a program of reviews and original research articles, the journal addresses major issues relating to drug therapy in older adults, including the management of specific diseases or disorders, particularly those associated with aging, age-related physiological changes impacting drug therapy, and issues related to drug utilization and prescribing.
Drugs & Aging offers a range of additional enhanced features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by a Key Points summary, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist readers in understanding important medical advances. The journal also provides the option to include various other types of enhanced features including slide sets, videos and animations. All enhanced features are peer reviewed to the same high standard as the article itself. Peer review is conducted using Editorial Manager®, supported by a database of international experts. This database is shared with other Adis journals.
- David Williamson
- Publishing model
- Hybrid. Open Choice – What is this?
- Impact factor: 2.846 (2018)
- Five year impact factor: 3.221 (2018)
- Submission to first decision: 42 days
- Acceptance to publication: 23 days
- Downloads: 132,849 (2018)